2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$4.12+$0.04 (+1.05%)
Price as of Nov 11, 2026 7:56 PM EST- $246.7MMarket Cap
- -6.85%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$4.12+$0.04 (+1.05%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.08 | ||
Change | -$0.010 (-0.24%) | ||
Open | $4.00 | ||
High | $4.18 | ||
Low | $4.00 | ||
Previous Close | $4.09 | ||
Volume | 1,381,381 | ||
30-Day Average Volume | 1,264,187 | ||
1-Week Change | 8.80% | ||
1-Month Change | -10.72% | ||
1-Year Change | -6.85% | ||
3-Year Change | 19.65% | ||
5-Year Change | -77.13% | ||
Fundamentals | |||
Shares Outstanding | 60.5M | ||
Total Assets | $382.3M | ||
Market Cap | $246.7M | ||
Enterprise Value | $184.8M | ||
Period: QTR TTM FY | |||
Revenue | $69.8M | ||
Net Income | -$22.6M | ||
Free Cash Flow | -$28.7M | ||
EBIT | -$22.4M | ||
EBITDA | -$20.4M | ||
Net Working Capital | $83.5M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue